|
I have asked my doctor this, and she says that it is absolutely NOT a foregone conclusion that we will recur, especially now that herceptin is being used more and more in the adjuvant setting. She wouldn't give me percentages because she felt it was too complicated with all of the other factors that get mixed in (to name a few: hormone status PLUS her2neu status, whether the patient took herceptin, what else the patient took WITH the herceptin, number of nodes positive versus number of nodes positive on a non-her2neu positive patient).
She did say that her2neu positive patients tend to present with more lymph nodes positive, and that would make ANYONE more likely to recur. Again, it is hard to factor out the other factors...
|